Abstract
ADRs and ADEs: Focus on drug-antibody conjugates, pharmacogenomics, and COVID19 vaccines
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have